# HB 330 - Introduced

90R1732 LHC-D

By: Plesa H.B. No. 330

A BILL TO BE ENTITLED

AN ACT

relating to the medical use of low-THC cannabis by patients with a medical condition that causes menstrual cramps.

BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:

### SECTION 1.

Section 169.003(a), Occupations Code, is amended to read as follows:

(a) A physician described by Section 169.002 may prescribe low-THC cannabis to a patient if:

(1) the patient is a permanent resident of the state;

(2) the physician complies with the registration requirements of Section 169.004; and

(3) the physician certifies to the department that:

(A) the patient is diagnosed with:

(i) epilepsy;

(ii) a seizure disorder;

(iii) multiple sclerosis;

(iv) spasticity;

(v) amyotrophic lateral sclerosis;

(vi) autism;

(vii) cancer;

(viii) an incurable neurodegenerative disease;

(ix) post-traumatic stress disorder;

(x) a condition that causes chronic pain;

(xi) traumatic brain injury;

(xii) Crohn's disease or other inflammatory bowel disease;

(xiii) a terminal illness or a condition for which a patient is receiving hospice or palliative care; \[<del>or</del>\]

(xiv) <ins>a condition that causes menstrual cramps, including premenstrual dysphoric disorder or dysmenorrhea; or</ins>

<ins>(xv)</ins> a medical condition that is approved for a research program under Subchapter F, Chapter 487, Health and Safety Code, and for which the patient is receiving treatment under that program; and

(B) the physician determines the risk of the medical use of low-THC cannabis by the patient is reasonable in light of the potential benefit for the patient.

### SECTION 2.

This Act takes effect September 1, 2027.
